The medical treatment of metastatic renal cell cancer in the elderly: Position paper of a SIOG Taskforce
- 31 January 2009
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 69 (1) , 64-72
- https://doi.org/10.1016/j.critrevonc.2008.08.002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Impact of Gender in Renal Cell Carcinoma: An Analysis of the SEER DatabaseEuropean Urology, 2007
- Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialThe Lancet, 2007
- Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Cytoreductive Nephrectomy in the Elderly Patient: The M. D. Anderson Cancer Center ExperienceJournal of Urology, 2007
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel‐Lindau gene statusBJU International, 2006
- Treatment Options in Metastatic Renal Carcinoma: An Embarrassment of RichesJournal of Clinical Oncology, 2006
- Immunotherapy for advanced renal cell cancerPublished by Wiley ,2004
- Serious Co-morbidity Among Unselected Cancer Patients Newly Diagnosed in the Southeastern Part of The Netherlands in 1993–1996Journal of Clinical Epidemiology, 1999